miR-23a suppression accelerates functional decline in the rNLS8 mouse model of TDP-43 proteinopathy

Skeletal muscle dysfunction may contribute to the progression and severity of amyotrophic lateral sclerosis (ALS). In the present study, we characterized the skeletal muscle pathophysiology in an inducible transgenic mouse model (rNLS8) that develops a TAR-DNA binding protein (TDP-43) proteinopathy...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Stavroula Tsitkanou, Paul A. Della Gatta, Gavin Abbott, Marita A. Wallace, Angus Lindsay, Frederico Gerlinger-Romero, Adam K. Walker, Victoria C. Foletta, Aaron P. Russell
Formato: article
Lenguaje:EN
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://doaj.org/article/9a0c4acf9c344503aa2f38b7f930adf4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9a0c4acf9c344503aa2f38b7f930adf4
record_format dspace
spelling oai:doaj.org-article:9a0c4acf9c344503aa2f38b7f930adf42021-11-26T04:24:22ZmiR-23a suppression accelerates functional decline in the rNLS8 mouse model of TDP-43 proteinopathy1095-953X10.1016/j.nbd.2021.105559https://doaj.org/article/9a0c4acf9c344503aa2f38b7f930adf42022-01-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S0969996121003089https://doaj.org/toc/1095-953XSkeletal muscle dysfunction may contribute to the progression and severity of amyotrophic lateral sclerosis (ALS). In the present study, we characterized the skeletal muscle pathophysiology in an inducible transgenic mouse model (rNLS8) that develops a TAR-DNA binding protein (TDP-43) proteinopathy and ALS-like neuropathology and disease progression; representative of >90% of all familial and sporadic ALS cases. As we previously observed elevated levels of miR-23a in skeletal muscle of patients with familial and sporadic ALS, we also investigated the effect of miR-23a suppression on skeletal muscle pathophysiology and disease severity in rNLS8 mice. Five weeks after disease onset TDP-43 protein accumulation was observed in tibialis anterior (TA), quadriceps (QUAD) and diaphragm muscle lysates and associated with skeletal muscle atrophy. In the TA muscle TDP-43 was detected in muscle fibres that appeared atrophied and angular in appearance and that also contained β-amyloid aggregates. These fibres were also positive for neural cell adhesion molecule (NCAM), but not embryonic myosin heavy chain (eMHC), indicating TDP-43/ β-amyloid localization in denervated muscle fibres. There was an upregulation of genes associated with myogenesis and NMJ degeneration and a decrease in the MURF1 atrophy-related protein in skeletal muscle. Suppression of miR-23a impaired rotarod performance and grip strength and accelerated body weight loss during early stages of disease progression. This was associated with increased AchRα mRNA expression and decreased protein levels of PGC-1α. The TDP-43 proteinopathy-induced impairment of whole body and skeletal muscle functional performance is associated with muscle wasting and elevated myogenic and NMJ stress markers. Suppressing miR-23a in the rNLS8 mouse model of ALS contributes to an early acceleration of disease progression as measured by decline in motor function.Stavroula TsitkanouPaul A. Della GattaGavin AbbottMarita A. WallaceAngus LindsayFrederico Gerlinger-RomeroAdam K. WalkerVictoria C. FolettaAaron P. RussellElsevierarticleAmyotrophic lateral sclerosisMotor neuron diseaserNLS8 miceTDP-43Skeletal musclemiR-23aNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571ENNeurobiology of Disease, Vol 162, Iss , Pp 105559- (2022)
institution DOAJ
collection DOAJ
language EN
topic Amyotrophic lateral sclerosis
Motor neuron disease
rNLS8 mice
TDP-43
Skeletal muscle
miR-23a
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
spellingShingle Amyotrophic lateral sclerosis
Motor neuron disease
rNLS8 mice
TDP-43
Skeletal muscle
miR-23a
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Stavroula Tsitkanou
Paul A. Della Gatta
Gavin Abbott
Marita A. Wallace
Angus Lindsay
Frederico Gerlinger-Romero
Adam K. Walker
Victoria C. Foletta
Aaron P. Russell
miR-23a suppression accelerates functional decline in the rNLS8 mouse model of TDP-43 proteinopathy
description Skeletal muscle dysfunction may contribute to the progression and severity of amyotrophic lateral sclerosis (ALS). In the present study, we characterized the skeletal muscle pathophysiology in an inducible transgenic mouse model (rNLS8) that develops a TAR-DNA binding protein (TDP-43) proteinopathy and ALS-like neuropathology and disease progression; representative of >90% of all familial and sporadic ALS cases. As we previously observed elevated levels of miR-23a in skeletal muscle of patients with familial and sporadic ALS, we also investigated the effect of miR-23a suppression on skeletal muscle pathophysiology and disease severity in rNLS8 mice. Five weeks after disease onset TDP-43 protein accumulation was observed in tibialis anterior (TA), quadriceps (QUAD) and diaphragm muscle lysates and associated with skeletal muscle atrophy. In the TA muscle TDP-43 was detected in muscle fibres that appeared atrophied and angular in appearance and that also contained β-amyloid aggregates. These fibres were also positive for neural cell adhesion molecule (NCAM), but not embryonic myosin heavy chain (eMHC), indicating TDP-43/ β-amyloid localization in denervated muscle fibres. There was an upregulation of genes associated with myogenesis and NMJ degeneration and a decrease in the MURF1 atrophy-related protein in skeletal muscle. Suppression of miR-23a impaired rotarod performance and grip strength and accelerated body weight loss during early stages of disease progression. This was associated with increased AchRα mRNA expression and decreased protein levels of PGC-1α. The TDP-43 proteinopathy-induced impairment of whole body and skeletal muscle functional performance is associated with muscle wasting and elevated myogenic and NMJ stress markers. Suppressing miR-23a in the rNLS8 mouse model of ALS contributes to an early acceleration of disease progression as measured by decline in motor function.
format article
author Stavroula Tsitkanou
Paul A. Della Gatta
Gavin Abbott
Marita A. Wallace
Angus Lindsay
Frederico Gerlinger-Romero
Adam K. Walker
Victoria C. Foletta
Aaron P. Russell
author_facet Stavroula Tsitkanou
Paul A. Della Gatta
Gavin Abbott
Marita A. Wallace
Angus Lindsay
Frederico Gerlinger-Romero
Adam K. Walker
Victoria C. Foletta
Aaron P. Russell
author_sort Stavroula Tsitkanou
title miR-23a suppression accelerates functional decline in the rNLS8 mouse model of TDP-43 proteinopathy
title_short miR-23a suppression accelerates functional decline in the rNLS8 mouse model of TDP-43 proteinopathy
title_full miR-23a suppression accelerates functional decline in the rNLS8 mouse model of TDP-43 proteinopathy
title_fullStr miR-23a suppression accelerates functional decline in the rNLS8 mouse model of TDP-43 proteinopathy
title_full_unstemmed miR-23a suppression accelerates functional decline in the rNLS8 mouse model of TDP-43 proteinopathy
title_sort mir-23a suppression accelerates functional decline in the rnls8 mouse model of tdp-43 proteinopathy
publisher Elsevier
publishDate 2022
url https://doaj.org/article/9a0c4acf9c344503aa2f38b7f930adf4
work_keys_str_mv AT stavroulatsitkanou mir23asuppressionacceleratesfunctionaldeclineinthernls8mousemodeloftdp43proteinopathy
AT pauladellagatta mir23asuppressionacceleratesfunctionaldeclineinthernls8mousemodeloftdp43proteinopathy
AT gavinabbott mir23asuppressionacceleratesfunctionaldeclineinthernls8mousemodeloftdp43proteinopathy
AT maritaawallace mir23asuppressionacceleratesfunctionaldeclineinthernls8mousemodeloftdp43proteinopathy
AT anguslindsay mir23asuppressionacceleratesfunctionaldeclineinthernls8mousemodeloftdp43proteinopathy
AT fredericogerlingerromero mir23asuppressionacceleratesfunctionaldeclineinthernls8mousemodeloftdp43proteinopathy
AT adamkwalker mir23asuppressionacceleratesfunctionaldeclineinthernls8mousemodeloftdp43proteinopathy
AT victoriacfoletta mir23asuppressionacceleratesfunctionaldeclineinthernls8mousemodeloftdp43proteinopathy
AT aaronprussell mir23asuppressionacceleratesfunctionaldeclineinthernls8mousemodeloftdp43proteinopathy
_version_ 1718409917991223296